High-Sensitivity Troponin T and Soluble Form of AXL as Long-Term Prognostic Biomarkers after Heart Transplantation
Open Access
- 29 August 2018
- journal article
- research article
- Published by Wiley in Disease Markers
- Vol. 2018, 1-7
Abstract
Antecedents. Cardiac allograft vasculopathy (CAV) is a frequent complication limiting the long-term (>1 year) survival after heart transplantation (HTx). CAV is initiated by endothelial dysfunction and can lead to severe cardiovascular (CV) complications. Since CAV is often clinically silent, biomarkers could help identifying HTx patients at risk of CAV and their severe complications. Aim. Evaluate the clinical yield of high-sensitivity cardiac troponin T (hs-cTnT), marker of cardiomyocyte damage, and the soluble form of AXL (sAXL), biomarker of endothelial dysfunction, to assess the prognosis of long-term cardiovascular (CV) events occurring after HTx. Methods. 96 patients were evaluated at least > 1 year after HTx. CAV was evaluated by coronary angiography or multisliced tomography, and hs-cTnT and sAXL measured 6 months before or after CAV evaluation. Patients were followed during 42 ± 15 months for a combined end point including cardiac death, angina or acute myocardial infarction, left ventricular ejection fraction < 50%, or heart failure not due to an acute rejection. Results. 51 patients (53%) presented CAV at evaluation; 21 of them had CV events. Hs-cTnT (56 ± 45 versus 20 ± 18 ng/L; ) and sAXL concentrations (98 ± 51 versus 26 ± 26 ng/L; ) were significantly higher in patients with CV events. Hs-cTnT (HR 1.03; 95% CI 1.015–1.042, ) and sAXL (HR 1.01; 95% CI 1.001–1.019, ) were independent predictors of CV events. A hs-cTnT concentration < 21 ng/L, detected by AUC ROC, predicted the absence of CV events with a predictive value of 91%; sAXL did not add more predictive value to hs-cTnT. Survival free of CV events was 92% in patients with hs-cTnT < 21 ng/L and 57% in those with hs-cTnT > 21 ng/L (). Conclusion. Hs-cTnT, but not sAXL, measured during the long-term follow-up of HTx patients appears as a helpful biomarker to identify patients at low risk of adverse CV outcomes.
Keywords
Funding Information
- European Regional Development Fund (RD12/0042/000)
- CIBERCV (RD12/0042/000)
- Instituto de Salud Carlos III (RD12/0042/000)
This publication has 26 references indexed in Scilit:
- The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report—2017; Focus Theme: Allograft ischemic timeThe Journal of Heart and Lung Transplantation, 2017
- Use of serum levels of high sensitivity troponin T, galectin-3 and C-terminal propeptide of type I procollagen at long term follow-up in heart failure patients with reduced ejection fraction: Comparison with soluble AXL and BNPInternational Journal of Cardiology, 2016
- Plasma Ultrasensitive Cardiac Troponin During Long-Term Follow-up of Heart Transplant RecipientsJournal of Cardiac Failure, 2014
- AXL receptor tyrosine kinase is increased in patients with heart failureInternational Journal of Cardiology, 2014
- Plasma protein biosignatures for detection of cardiac allograft vasculopathyThe Journal of Heart and Lung Transplantation, 2013
- Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndromeAmerican Heart Journal, 2011
- International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy—2010The Journal of Heart and Lung Transplantation, 2010
- Revision of the 1990 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart RejectionThe Journal of Heart and Lung Transplantation, 2005
- B-Type Natriuretic Peptide as a Marker of Allograft Rejection After Heart TransplantationThe Journal of Heart and Lung Transplantation, 2005
- Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantationThe American Journal of Cardiology, 2004